HIGH RISK NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Clinical trials for HIGH RISK NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HIGH RISK NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for HIGH RISK NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could this trial cut a second surgery for bladder cancer patients?
Disease control Recruiting nowThis study is testing if a new approach can safely help some bladder cancer patients avoid a second surgery. It compares a special imaging-guided surgery to the current standard, which involves two surgeries. The goal is to see if the new method controls the cancer just as well w…
Matched conditions: HIGH RISK NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE4 • Sponsor: University of Roma La Sapienza • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New vaccine aims to train immune system to fight tough bladder cancer
Disease control Recruiting nowThis early-stage study is testing whether a new vaccine (IO102-IO103) combined with an existing immunotherapy drug (pembrolizumab) is safe and effective for patients with high-risk bladder cancer that hasn't responded to standard BCG treatment. The vaccine is designed to teach th…
Matched conditions: HIGH RISK NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC